276 related articles for article (PubMed ID: 33552861)
1. Nitric Oxide-Driven Nanomotor for Deep Tissue Penetration and Multidrug Resistance Reversal in Cancer Therapy.
Wan MM; Chen H; Da Wang Z; Liu ZY; Yu YQ; Li L; Miao ZY; Wang XW; Wang Q; Mao C; Shen J; Wei J
Adv Sci (Weinh); 2021 Feb; 8(3):2002525. PubMed ID: 33552861
[TBL] [Abstract][Full Text] [Related]
2. Nanogel-based nitric oxide-driven nanomotor for deep tissue penetration and enhanced tumor therapy.
Wang J; Liu J; Sümbelli Y; Shao J; Shi X; van Hest JCM
J Control Release; 2024 Jun; 372():59-68. PubMed ID: 38866242
[TBL] [Abstract][Full Text] [Related]
3. Deep Penetration of Nanolevel Drugs and Micrometer-Level T Cells Promoted by Nanomotors for Cancer Immunochemotherapy.
Chen H; Shi T; Wang Y; Liu Z; Liu F; Zhang H; Wang X; Miao Z; Liu B; Wan M; Mao C; Wei J
J Am Chem Soc; 2021 Aug; 143(31):12025-12037. PubMed ID: 34320319
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
5. Pt/DOX Nanomotors Enhance Penetration in the Deep Tumor by Positive Chemotaxis.
Zhong H; Zhang Z; Zhou Y; Wu L; Ke P; Lu Y; Dai Q; Bao X; Xia Y; Yang Q; Tan X; Wei Q; Xu W; Han M; Ma L
ACS Appl Mater Interfaces; 2022 Aug; 14(33):38172-38184. PubMed ID: 35943232
[TBL] [Abstract][Full Text] [Related]
6. Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy.
Wang L; Chang Y; Feng Y; Li X; Cheng Y; Jian H; Ma X; Zheng R; Wu X; Xu K; Zhang H
Nano Lett; 2019 Oct; 19(10):6800-6811. PubMed ID: 31466437
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared-light induced nanoparticles with enhanced tumor tissue penetration and intelligent drug release.
Zhang Y; Liu Y; Gao X; Li X; Niu X; Yuan Z; Wang W
Acta Biomater; 2019 May; 90():314-323. PubMed ID: 30981751
[TBL] [Abstract][Full Text] [Related]
8. Light-Switchable Yolk-Mesoporous Shell UCNPs@MgSiO
Li S; Song X; Zhu W; Chen Y; Zhu R; Wang L; Chen X; Song J; Yang H
ACS Appl Mater Interfaces; 2020 Jul; 12(27):30066-30076. PubMed ID: 32393026
[TBL] [Abstract][Full Text] [Related]
9. Systematic Research and Evaluation Models of Nanomotors for Cancer Combined Therapy.
Wan M; Wang Q; Li X; Xu B; Fang D; Li T; Yu Y; Fang L; Wang Y; Wang M; Wang F; Mao C; Shen J; Wei J
Angew Chem Int Ed Engl; 2020 Aug; 59(34):14458-14465. PubMed ID: 32302052
[TBL] [Abstract][Full Text] [Related]
10. Bio-inspired nitric-oxide-driven nanomotor.
Wan M; Chen H; Wang Q; Niu Q; Xu P; Yu Y; Zhu T; Mao C; Shen J
Nat Commun; 2019 Feb; 10(1):966. PubMed ID: 30814497
[TBL] [Abstract][Full Text] [Related]
11. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
[TBL] [Abstract][Full Text] [Related]
12. Design real-time reversal of tumor multidrug resistance cleverly with shortened carbon nanotubes.
Wu P; Li S; Zhang H
Drug Des Devel Ther; 2014; 8():2431-8. PubMed ID: 25525333
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy.
Hu C; Cun X; Ruan S; Liu R; Xiao W; Yang X; Yang Y; Yang C; Gao H
Biomaterials; 2018 Jun; 168():64-75. PubMed ID: 29626787
[TBL] [Abstract][Full Text] [Related]
14. Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound.
Choi Y; Han H; Jeon S; Yoon HY; Kim H; Kwon IC; Kim K
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33076520
[TBL] [Abstract][Full Text] [Related]
15. Sequential Intra-Intercellular Delivery of Nanomedicine for Deep Drug-Resistant Solid Tumor Penetration.
He Y; Cong C; Li L; Luo L; He Y; Hao Z; Gao D
ACS Appl Mater Interfaces; 2020 Feb; 12(8):8978-8988. PubMed ID: 32020804
[TBL] [Abstract][Full Text] [Related]
16. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
17. DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells.
Wang J; Li N; Cao L; Gao C; Zhang Y; Shuai Q; Xie J; Luo K; Yang J; Gu Z
J Mater Chem B; 2020 Feb; 8(6):1157-1170. PubMed ID: 31951231
[TBL] [Abstract][Full Text] [Related]
18. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
19. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
Desai PB; Duan J; Sridhar R; Damle BD
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
[TBL] [Abstract][Full Text] [Related]
20. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.
Wang AT; Liang DS; Liu YJ; Qi XR
Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
